JALRA 50MG TABLET 15'S

JALRA 50MG TABLET 15'S is used to treat type 2 diabetes by helping to regulate blood sugar levels. It is typically used in combination with diet and exercise, as well as other medications as needed.

The most common side effects of JALRA 50MG TABLET 15'S include headache, dizziness, nausea, vomiting, diarrhea, and upper respiratory tract infections. In rare cases, it may cause more serious side effects such as pancreatitis, hypoglycemia, allergic reactions, or liver problems.

JALRA 50MG TABLET 15'S is not approved for use in children under the age of 18, and its safety and efficacy in this population have not been established.

JALRA 50MG TABLET 15'S is usually taken orally, with meals. The recommended dosage may vary depending on the individual needs and response of the patient, and it should be determined by a healthcare provider.

The use of JALRA 50MG TABLET 15'S during pregnancy or breastfeeding is not recommended, as its safety in these situations has not been established. Women who are pregnant or breastfeeding should consult with their healthcare provider before taking JALRA 50MG TABLET 15'S or any other medication.

Patients with moderate to severe kidney or liver problems should use JALRA 50MG TABLET 15'S with caution and at a reduced dose. A healthcare provider should be consulted before taking JALRA 50MG TABLET 15'S in these situations.

If a dose of JALRA 50MG TABLET 15'S is missed, it should be taken as soon as possible unless it is close to the time of the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed.

JALRA 50MG TABLET 15'S should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a dry place away from direct sunlight and heat. It should be kept in its original packaging until it is ready to be used. Unused or expired medication should be disposed of properly according to local regulations.